Evidence map›Paper›PMID 41264087›Full record

ArticleRadiological physics and technology2026

Atlas selection methods for multi-atlas-based segmentation in breast cancer radiotherapy planning.

Anri Minamitake, Ryuji Murakami, Yasuhiro Doi, Masato Maruyama, Kosuke Morita

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anri MinamitakeGraduate School of Health Sciences, Kumamoto University, 4-24-1 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto, 862-0976, Japan.
Ryuji MurakamiDepartment of Radiation Therapy Technology, Faculty of Life Sciences, Kumamoto University, 4-24-1 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto, 862-0976, Japan. murakami@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0002-8432-7988
Yasuhiro DoiMedical Radiology Technology Department, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan.
Masato MaruyamaMedical Radiology Technology Department, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan.
Kosuke MoritaMedical Radiology Technology Department, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated atlas selection methods for multi-atlas-based segmentation (MABS) in breast cancer radiotherapy planning. Forty-five patients were divided into 30 atlas and 15 test cases. The 30 atlases were stratified into three groups based on breast separation, height, and volume. Firstly, MABS was performed on each of the 30 atlas cases using the remaining 29 atlases. Secondly, MABS was performed on 15 test cases using the 30 atlases. The Dice similarity coefficient (DSC) was calculated to assess the agreement between MABS and manual segmentation. The DSC was found to increase as more atlases were selected. Although this led to an increase in the computational time, the implementation of patient stratification reduced the computational time compared with using the entire dataset. Atlas selection from the height-matched and volume-matched tertile datasets provided median DSC values > 0.9. Breast height may be a practical surrogate for breast volume which is unknown before segmentation.

Indexed as

Breast NeoplasmsImage Processing, Computer-AssistedRadiotherapy Planning, Computer-AssistedFemaleHumansAtlas-based segmentation (ABS)Atlas selectionBreast cancerMulti-atlas-based segmentation (MABS)Radiotherapy (RT) planning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.